New Study Examines In Vitro Diagnostics Investments, Timelines, and Structure

RESEARCH TRIANGLE PARK, NC--(Marketwire - January 23, 2008) - A study released by Cutting Edge Information finds that, among surveyed companies, only one third of in vitro diagnostics (IVD) companies have $1 million or more to spend on product marketing. The report, "In Vitro Diagnostics: Development Through Postmarket" (http://www.DiagnosticTrends.com/), explores trends in diagnostics' development and marketing.

Findings provide benchmarks for each stage of the commercialization process, including product development, launch marketing and postmarket management. Highlights include the following:

--  Investments in marketing, research & development, and manufacturing
--  Reimbursement staffing levels and budgets
--  Staff investments in marketing, sales, and postmarket monitoring
--  Sales hiring and training best practices
--  Profiles of IVD brands
    

Based on interviews with industry executives, the report offers insights into the unique challenges that IVD product teams confront. It also gives recommendations on how to maximize product development resources and opportunities. Findings will enable brand teams to improve their IVD management efforts.

"The IVD industry is growing and is a key component of healthcare," said Eric Bolesh, lead author of the report. "But because of relatively limited resources, diagnostic companies' brands may struggle to find success. Our report helps companies with their staffing and spending decisions. We emphasize the importance of market-focused product development."

Download a free summary of "In Vitro Diagnostics: Development Through Postmarket" or purchase the report at: http://www.cuttingedgeinfo.com/diagnostictrends/PH101_Download.asp#body.

Contact Information: CONTACT: Eric Bolesh 919-433-0209